R Hubbard - BlackRock Science Independent Trustee
| BST Etf | USD 34.21 0.37 1.09% |
| Age | 61 |
| Tenure | 11 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Christopher Morin | Pimco Corporate Income | 40 | |
| Stayce Harris | BlackRock Health Sciences | 62 | |
| Jeffrey Lee | BlackRock Health Sciences | N/A | |
| Gerald Maginnis | Cohen Steers Reit | 65 | |
| Brian Pittluck | Pimco Corporate Income | 44 | |
| Richard Froio | Eaton Vance Enhanced | 53 | |
| Daphne Richards | Cohen Steers Qualityome | 54 | |
| C Ward | Cohen Steers Qualityome | 74 | |
| Daphne Richards | Cohen Steers Reit | 54 | |
| Christopher Accettella | BlackRock Utility Infrastructur | N/A | |
| Jason Nagler | Pimco Corporate Income | 39 | |
| Kelly McEwen | Reaves Utility If | 36 | |
| Deidre Walsh | Eaton Vance Enhanced | 50 | |
| Xiang Liu | BlackRock Health Sciences | N/A | |
| Dana DeVivo | Cohen And Steers | 39 | |
| Catherine Lynch | BlackRock Health Sciences | 60 | |
| MBA MD | Tekla Healthcare Investors | N/A | |
| Dana DeVivo | Cohen Steers Qualityome | 39 | |
| Benjamin Morton | Cohen And Steers | 46 | |
| Sarah Cogan | Pimco Corporate Income | 65 | |
| J Holloman | BlackRock Health Sciences | 66 | |
BlackRock Science Tech Money Managers
| Henry Gabbay, Independent Trustee | ||
| Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| R Hubbard, Independent Trustee | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Neal Andrews, Chief Financial Officer | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 33.68 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 18.53 % | ||||
| Number Of Shares Shorted | 14.74 K | ||||
| Price To Earning | 5.78 X | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 5.41 X | ||||
| Number Of Employees | 17 | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.